Login to Your Account

Clinic Roundup

Monday, September 30, 2013
• Bioheart Inc., of Sunrise, Fla., reported preliminary data from its Phase I ANGEL trial, showing at the three-month time point that patients are demonstrating an average improvement in exercise capacity or a six-minute walk test of 47 meters.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription